Rivaxa 10 Tablet 14

Rivaxa 10 Tablet 14 is used for the following:

• Preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation

• Managing deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Stopping recurrent DVT and PE after initial management

• Lowering the risk of venous thromboembolism (VTE) in patients following knee or hip replacement surgery

Here are some guidelines to follow while taking Rivaxa 10 Tablet 14:

• Swallow the tablet whole with a glass of water.

• Do not crush or chew the tablet.

• It is crucial not to stop taking this medicine without consulting your doctor first.

Rivaxa 10 Tablet 14 is taken orally.

Rivaxa 10 Tablet 14 contains rivaroxaban (10 mg). It impacts your body in the following ways:

• Selective Factor Xa Inhibition: This medicine works by selectively blocking an enzyme in your body known as factor Xa, which plays a critical role in blood clot formation.

• Decreased Thrombin Generation: By inhibiting factor Xa, rivaroxaban reduces the generation of thrombin, a protein that causes blood to clot.

• Direct Factor Xa Inhibition: Unlike some other anticoagulants, rivaroxaban directly inhibits factor Xa, without needing any additional substances like antithrombin III. This direct action makes it efficient in preventing clot formation.

• Store Rivaxa 10 Tablet 14 at room temperature, ideally below 30°C.

• Keep the tablet in its original packaging to protect it from moisture.

• Avoid exposure to direct sunlight or heat sources.

• Always keep this medicine out of reach of children.

• Ensure you use the tablet before its expiry date.

• Make sure to stay well-hydrated. This is important as dehydration can increase the risk of blood clotting, which Rivaxa 10 Tablet 14 helps manage.

• Regular low-intensity exercise such as walking or swimming can help improve circulation and reduce the risk of blood clots. Please consult your doctor before starting any new exercise regimen.